本文章的学术内容和语言评估
本文章的CrossCheck查重和Google搜索
本文章的学术规范
本文章的引用
本文章的通讯作者
本文章的研究领域
本文章的类型
本文章的开放获取政策
本文章的Google引用次数
本文章的点击和下载次数
- 本文章浏览次数 (7521)
All Articles published online
|
Publishing Process of This Article
|
Jun 27, 2023 (publication date) through Dec 18, 2024
本文章的被引频次
本文章的期刊信息
出版物名称
World Journal of Hepatology
ISSN
1948-5182
本文章的出版商
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhang CY, Liu S, Yang M. Treatment of liver fibrosis: Past, current, and future. World J Hepatol 2023; 15(6): 755-774 [PMID: 37397931 DOI: 10.4254/wjh.v15.i6.755] |
|---|---|
| URL: | https://www.wjgnet.com/1009-3079/full/v15/i6/755.htm |
| 编号 | Citing Articles |
| 1 |
Girish L. Gupte, Anshu Srivastava. Chronic Liver Disease in Children: From Diagnosis to Liver Transplantation. Indian Journal of Pediatrics 2024; 91(3): 260 doi: 10.1007/s12098-024-05030-3
|
| 2 |
Peng Ji, Yan Li, Zihan Wang, Siyu Jia, Xinyi Jiang, Hui Chen, Qun Wang. Advances in precision gene editing for liver fibrosis: From technology to therapeutic applications. Biomedicine & Pharmacotherapy 2024; 177: 117003 doi: 10.1016/j.biopha.2024.117003
|
| 3 |
Arndt Vogel, Robert C. Grant, Tim Meyer, Gonzalo Sapisochin, Grainne M. O’Kane, Anna Saborowski. Adjuvant and neoadjuvant therapies for hepatocellular carcinoma. Hepatology 2023; doi: 10.1097/HEP.0000000000000726
|
| 4 |
Ming Yang, Chun-Ye Zhang. Interleukins in liver disease treatment. World Journal of Hepatology 2024; 16(2): 140-145 doi: 10.4254/wjh.v16.i2.140
|
| 5 |
Sayed H. Seif el-Din, Olfat A. Hammam, Shahira M. Ezzat, Samira Saleh, Marwa M. Safar, Walaa H. El-Maadawy, Naglaa M. El-Lakkany. Hydroxysafflor yellow A protects against thioacetamide-induced liver fibrosis in rats via suppressing proinflammatory/fibrogenic mediators and promoting hepatic stellate cell senescence and apoptosis. Asian Pacific Journal of Tropical Biomedicine 2023; 13(8): 348 doi: 10.4103/2221-1691.383689
|
| 6 |
Nidal Jaradat, Mohammed Hawash, Majid Sharifi-Rad, Ali Shakhshir, Shorooq Sobuh, Fatima Hussein, Linda Issa, Sondos Hamamrhe, Eman Al-Sheikh, Alaa Naser Ibrahim. Insights into free radicals scavenging, α-Amylase inhibition, cytotoxic and antifibrotic activities unveiled by Peganum harmala extracts. BMC Complementary Medicine and Therapies 2024; 24(1) doi: 10.1186/s12906-024-04602-2
|
| 7 |
A. V. Vasyutin, V. V. Tsukanov, N. E. Veselova, E. G. Gorchilova, J. L. Tonkikh, A. A. Savchenko, A. G. Borisov. Association of neutropenia and decreased neutrophil function with liver fibrosis in patients with Opisthorchis felineus invasion. Meditsinskiy sovet = Medical Council 2024; (15): 62 doi: 10.21518/ms2024-339
|
| 8 |
Tamer A. Addissouky, Majeed M. A. Ali, Ibrahim El Tantawy El Sayed, Yuliang Wang. Emerging advanced approaches for diagnosis and inhibition of liver fibrogenesis. The Egyptian Journal of Internal Medicine 2024; 36(1) doi: 10.1186/s43162-024-00283-y
|
| 9 |
Aneta Sokal-Dembowska, Sara Jarmakiewicz-Czaja, Katarzyna Ferenc, Rafał Filip. Can Nutraceuticals Support the Treatment of MASLD/MASH, and thus Affect the Process of Liver Fibrosis?. International Journal of Molecular Sciences 2024; 25(10): 5238 doi: 10.3390/ijms25105238
|
| 10 |
Devadoss J. Samuvel, John J. Lemasters, C. James Chou, Zhi Zhong. LP340, a novel histone deacetylase inhibitor, decreases liver injury and fibrosis in mice: role of oxidative stress and microRNA-23a. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1386238
|
| 11 |
Sara Maher, Shimaa Atta, Manal Kamel, Olfat Ali Hammam, Hend Okasha. Therapeutic Potential and Mechanistic Insights of a Novel Synthetic α-Lactalbumin-Derived Peptide for the Treatment of Liver Fibrosis. Journal of Clinical and Experimental Hepatology 2024; : 102488 doi: 10.1016/j.jceh.2024.102488
|
| 12 |
Watunyoo Buakaew, Sucheewin Krobthong, Yodying Yingchutrakul, Pachuen Potup, Yordhathai Thongsri, Krai Daowtak, Antonio Ferrante, Kanchana Usuwanthim. Investigating the Antifibrotic Effects of β-Citronellol on a TGF-β1-Stimulated LX-2 Hepatic Stellate Cell Model. Biomolecules 2024; 14(7): 800 doi: 10.3390/biom14070800
|
| 13 |
Jia Ming Nickolas Teo, Guang Sheng Ling. Sphingosine Kinase 1 – A Therapeutic Opportunity for Alleviating Liver Fibrosis?. Cellular and Molecular Gastroenterology and Hepatology 2024; : 101430 doi: 10.1016/j.jcmgh.2024.101430
|
| 14 |
Man Na, Xingbiao Yang, Yongkun Deng, Zhaoheng Yin, Mingwei Li. Endoplasmic reticulum stress in the pathogenesis of alcoholic liver disease. PeerJ 2023; 11: e16398 doi: 10.7717/peerj.16398
|
| 15 |
Galit Weinstein, Yochai Schonmann, Hanny Yeshua, Shira Zelber‐Sagi. The association between liver fibrosis score and incident dementia: A nationwide retrospective cohort study. Alzheimer's & Dementia 2024; 20(8): 5385 doi: 10.1002/alz.14033
|
| 16 |
Sara T. Elazab, Walter H. Hsu. Ferulic acid ameliorates concanavalin A-induced hepatic fibrosis in mice via suppressing TGF-β/smad signaling. Toxicology and Applied Pharmacology 2024; 492: 117099 doi: 10.1016/j.taap.2024.117099
|
| 17 |
Simona Cernea. NAFLD Fibrosis Progression and Type 2 Diabetes: The Hepatic–Metabolic Interplay. Life 2024; 14(2): 272 doi: 10.3390/life14020272
|
| 18 |
Mohammadjavad Sotoudeheian. Galectin-3 and Severity of Liver Fibrosis in Metabolic
Dysfunction-Associated Fatty Liver Disease. Protein & Peptide Letters 2024; 31(4): 290 doi: 10.2174/0109298665301698240404061300
|
| 19 |
Joey A. Muns, Erik Schooten, Rychon D. J. van Dasselaar, Yvet E. Noordman, Kevin Adamzek, Arthur C. Eibergen, Sebas D. Pronk, Sagel Cali, Niels J. Sijbrandi, Eugen Merkul, Sabrina Oliveira, Paul M.P. van Bergen en Henegouwen, R. Bart Takkenberg, Joanne Verheij, Stan F.J. van de Graaf, Bart A. Nijmeijer, Guus A.M.S. van Dongen. Preclinical targeting of liver fibrosis with a 89Zr-labeled Fibrobody® directed against platelet derived growth factor receptor-β. European Journal of Nuclear Medicine and Molecular Imaging 2024; 51(12): 3545 doi: 10.1007/s00259-024-06785-9
|
| 20 |
Pasquale Rapacciuolo, Claudia Finamore, Cristina Di Giorgio, Bianca Fiorillo, Carmen Massa, Ginevra Urbani, Silvia Marchianò, Martina Bordoni, Chiara Cassiano, Elva Morretta, Lucio Spinelli, Antonio Lupia, Federica Moraca, Michele Biagioli, Valentina Sepe, Maria Chiara Monti, Bruno Catalanotti, Stefano Fiorucci, Angela Zampella. Design, Synthesis, and Pharmacological Evaluation of Dual FXR-LIFR Modulators for the Treatment of Liver Fibrosis. Journal of Medicinal Chemistry 2024; 67(20): 18334 doi: 10.1021/acs.jmedchem.4c01651
|
| 21 |
Vasilii Slautin, Konstantin Konyshev, Ilya Gavrilov, Olga Beresneva, Irina Maklakova, Dmitry Grebnev. Fucoxanthin Enhances the Antifibrotic Potential of Placenta-derived Mesenchymal Stem Cells in a CCl4-induced Mouse Model of Liver. Current Stem Cell Research & Therapy 2024; 19(11): 1484 doi: 10.2174/011574888X279940231206100902
|
| 22 |
Feng Chen, Qianhui Li, Xiaomin Xu, Fei Wang. Non-invasive Diagnostic Indicators and Antiviral Treatment Efficacy in CHB Patients with Different Liver Histopathological Degrees. Hepatitis Monthly 2024; 24(1) doi: 10.5812/hepatmon-147016
|
| 23 |
Wiebke‐Felicitas Nierath, Emily Leitner, Sabrina Reimann, Rico Schwarz, Burkhard Hinz, André Bleich, Brigitte Vollmar, Dietmar Zechner. GSK805 inhibits alpha‐smooth muscle expression and modulates liver inflammation without impairing the well‐being of mice. The FASEB Journal 2024; 38(16) doi: 10.1096/fj.202400733R
|
| 24 |
Xiaodong Li, Nana Li, Yujie Wang, Qixiang Han, Boshi Sun. Research Progress of Fibroblasts in Human Diseases. Biomolecules 2024; 14(11): 1478 doi: 10.3390/biom14111478
|
| 25 |
Daisuke Taguchi, Yohei Shirakami, Hiroyasu Sakai, Toshihide Maeda, Takao Miwa, Masaya Kubota, Kenji Imai, Takashi Ibuka, Masahito Shimizu. High-Fat Diet Delays Liver Fibrosis Recovery and Promotes Hepatocarcinogenesis in Rat Liver Cirrhosis Model. Nutrients 2024; 16(15): 2506 doi: 10.3390/nu16152506
|
| 26 |
Xiao-Ling Wang, Meng Yang, Ying Wang. Roles of transforming growth factor-β signaling in liver disease. World Journal of Hepatology 2024; 16(7): 973-979 doi: 10.4254/wjh.v16.i7.973
|
| 27 |
Miguel Jiménez‑Luévano, Ana Jiménez‑Partida, Erick Sierra‑Díaz, Eduardo Orozco‑Alonso, Martha Villaseñor‑García, Alejandro Bravo‑Hernández, Jesús Gutiérrez‑Ortíz, Alejandro Bravo‑Cuellar, Georgina Hernández‑Flores. Prolonged use of pentoxifylline increases the life expectancy of patients with compensated cirrhosis: A 20‑year retrospective study. Biomedical Reports 2024; 21(6) doi: 10.3892/br.2024.1861
|
| 28 |
Shradha P Kakde, Maham Mushtaq, Maryyam Liaqat, Husnain Ali, Muhammad Muaz Mushtaq, Muhammad Asad Sarwer, Sami Ullah, Muhammad Wali Hassan, Asma Khalid, Syed Faqeer Hussain Bokhari. Emerging Therapies for Non-Alcoholic Steatohepatitis (NASH): A Comprehensive Review of Pharmacological and Non-Pharmacological Approaches. Cureus 2024; doi: 10.7759/cureus.69129
|
| 29 |
Vasudevan Sekar, Venkateish VP, Vani Vijay, Annapoorna BR, Nivya Vijayan, Madan Kumar Perumal. Inhibition of hepatic stellate cell activation by nutraceuticals: an emphasis on mechanisms of action. Journal of Food Science and Technology 2024; 61(11): 2046 doi: 10.1007/s13197-024-06002-3
|
| 30 |
Xiaoxin Liu, Ninglin Xia, Qinwei Yu, Ming Jin, Zifan Wang, Xue Fan, Wen Zhao, Anqin Li, Zhenzhou Jiang, Luyong Zhang. Silybin Meglumine Mitigates CCl4-Induced Liver Fibrosis and Bile Acid Metabolism Alterations. Metabolites 2024; 14(10): 556 doi: 10.3390/metabo14100556
|